Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Perioperative Dexmedetomidine Infusion on Microcirculation and Kidney and Intestinal Injury in Kidney Transplant Recipients
NCT02707809Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2016
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of dexmedetomidine in acute kidney injury (AKI), Intestinal injury and Microcirculatory dysfunction (MVD) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoints: Total small vessel density of sublingual microcirculation and Creatinine level. Started Aug 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney injury (AKI)Intestinal injuryMicrocirculatory dysfunction (MVD)
Beyond the preview
Go deeper on NCT02707809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02707809.